Mark W. Kroll
Independent DirectorDr. Mark W. Kroll, Ph.D., FACC, FHRS, FIEEE, FAIMBE, co-founded Omcare Inc. (formerly known as Anser Innovation LLC) in 2011. He serves as Scientific Advisory Board at BaroPace, Inc. Dr. Kroll co-founded Harbinger Medical Inc., in 1993 and served as its Secretary. Dr. Kroll served as Senior Vice President and Chief Technology Officer of the Cardiac Rhythm Management Division of device giant St. Jude Medical Inc. from 2001 to 2005. From 1995 to 2005, Dr. Kroll has held various Executive level positions within St. Jude Medical Inc., including as Vice President of the Tachycardia business unit. Dr. Kroll has experience with cardiovascular devices and instrumentation. Previously, he served as Vice President of Research for the Angemed division of Angeion Inc. from 1991 to 1995, where he was instrumental in the development of the technology which led to the first ICD smaller than 90 ml in volume. He served as Vice President of R&D at Vital Heart Systems from 1985 to 1991 and Vice President R&D at Intercomp Company from 1978 to 1985, after working as a Circuit Designer at Medtronic. From 1999 to 2001, he served as Senior Vice President for Technology and Design at the California Polytechnic State University. He has been a Director of Medisyn Technologies, Inc. since March 2006 and TASER International Inc. since January 2003. He served as a Director of Recombinetics, Inc., Harbinger Medical, Inc., Arrowhead Offshore Partners Ltd. and Ionix Medical, Inc. He has been an Independent Director of Haemonetics Corporation since January 1, 2006. He served as the Chairman of NewCardio, Inc. from March 18, 2008 to June 17, 2011. He served as a Director of NewCardio, Inc. from March 18, 2008 to January 1, 2012. He serves as an Adjunct Full Professor of Biomedical Engineering and Lecturer on Cardiovascular Physiology at California Polytechnic University - San Luis Obispo, Calif. and as an Adjunct Full Professor of Biomedical Engineering at the University of Minnesota. Dr. Kroll holds the position of Distinguished Faculty at the UCLA Anderson School of Business Creativity and Innovation annual program. He is the named Inventor of more than 350 U.S. patents as well as numerous international patents. He is widely recognized as the most prolific inventor of electrical medical device patents in the world. In addition, he is co-author of the books Implantable Cardioverter Defibrillator Therapy (1996) and Cardiac Bioelectric Therapy (in press), contributor to treatises, public speaker and author of more than 150 papers and abstracts. Dr. Kroll has received numerous awards and recognition for his pioneering work. He has been listed in 'Who's Who in Science and Engineering' since 1992, has been named a Fellow of both the American College of Cardiology and the Heart Rhythm Society, Institute of Electronics and Electrical Engineering, the American Institute for Medicine and Biology in Engineering. He was Retired Senior Executive Officer, St. Jude Medical, Inc. In 2010, Dr. Kroll was awarded the Career Achievement Award in Biomedical Engineering, among the highest international awards in biomedical engineering. He served as Independent Director of Axon Enterprise, Inc since January 2003 until May 09, 2024. Dr. Kroll holds a B.S. degree in Mathematics and an M.S. degree and a Ph.D. degree in Electrical Engineering from the University of Minnesota in 1987 and an M.B.A. degree from the University of St. Thomas in 1990. Dr. Kroll is a well-known pioneer in the field of electrical medical devices and a distinguished technology expert throughout the global medical device industry. He has Advanced mathematical and scientific education and technology and scientific accomplishments as recognized by “Fellow” designations from IEEE and AIMBE provide a strong scientific background that is beneficial to the Company. His scientific accomplishments as recognized by “Fellow” designations from the American College of Cardiology and the Heart Rhythm Society provide invaluable skills and experience to the TASER business. His service on Haemonetic Corporation board of directors as well as leadership positions at St. Jude Medical, Incorporatedprovides beneficial experience in management and oversight. He brought to the Haemonetics Corp. board extensive expertise in the areas of medical innovation and technology.
Positions
- Company NameHaemonetics CorporationStock CodeHAEPositionIndependent DirectorColleagues
- CAChristopher A. SimonCEO, President & Director
- EMEllen M. ZaneIndependent Chairman
- JCJames C. D'AreccaCFO, Executive VP & Financial Officer
- FWFrank W. ChanExecutive VP & COO
- MLMichelle L. BasilExecutive VP, General Counsel & Secretary
- RGRoy GalvinExecutive VP & Chief Commercial Officer
- RERobert E. AbernathyIndependent Director
- LELloyd Emerson JohnsonIndependent Director
